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Abstract
Plasmids are mobile genetic elements that play a key role in the evolution of bacteria by mediating genome plasticity and lateral
transfer of useful genetic information. Although originally considered to be exclusively circular, linear plasmids have also been
identified in certain bacterial phyla, notably the actinomycetes. In some cases, linear plasmids engage with chromosomes in an
intricate evolutionary interplay, facilitating the emergence of new genome configurations by transfer and recombination or
plasmid integration. Genome sequencing of Streptomyces clavuligerusATCC 27064, a Gram-positive soil bacterium known for
its production of a diverse array of biotechnologically important secondary metabolites, revealed a giant linear plasmid of 1.8 Mb
in length. This megaplasmid (pSCL4) is one of the largest plasmids ever identified and the largest linear plasmid to be sequenced.
It contains more than 20% of the putative protein-coding genes of the species, but none of these is predicted to be essential for
primary metabolism. Instead, the plasmid is densely packed with an exceptionally large number of gene clusters for the potential
production of secondary metabolites, including a large number of putative antibiotics, such as staurosporine, moenomycin,
b-lactams, and enediynes. Interestingly, cross-regulation occurs between chromosomal and plasmid-encoded genes. Several
factors suggest that the megaplasmid came into existence through recombination of a smaller plasmid with the arms of the
main chromosome. Phylogenetic analysis indicates that heavy traffic of genetic information between Streptomyces plasmids
and chromosomes may facilitate the rapid evolution of secondary metabolite repertoires in these bacteria.
Key words: genome sequence, chromosomal evolution, natural products, Streptomyces clavuligerus.
Introduction
Prokaryotic chromosomes were originally thought to lack
many of the features that characterize eukaryotic chromo-
somes, such as linearity and the possession of telomeres
(Bendich and Drlica 2000). However, during recent decades,
a few bacterial taxa have been shown to have linear chro-
mosomes that contain telomere-like structures (Hinnebusch
and Tilly 1993). Among these are the high-GC, Gram-
positive, soil-dwelling Streptomyces bacteria (Chen et al.
1994; Hopwood 2006), renowned for their capacity to pro-
duce a vast array of natural products. Their linear chromo-
somes are relatively long (8–10 Mb) and consist of
ª The Author(s) 2010. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.
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a conserved ‘‘core’’ of 5–6 Mb and variable ‘‘arm’’ regions
(Hopwood 2006). Nearly all genes that are likely to be
unconditionally essential are located within the core. Inter-
estingly, besides possessing linear chromosomes, streptomy-
cetes also often contain linear plasmids, extrachromosomal
DNA molecules that replicate independently from the main
chromosome and contain their own telomere-like structures
(Chater and Kinashi 2007; Chen 2007). Evidence is accumu-
lating that the evolution of streptomycete chromosomes
and plasmids can be very dynamic because of their relative
instability (Volff and Altenbuchner 1998; Chen et al. 2002;
Widenbrant et al. 2007).
Substantial effort in the study of streptomycetes is fo-
cused on the secondary metabolites they produce. Many
bacterial secondary metabolites or their derivatives are used
as antimicrobial agents, whereas some are used as anti-
tumor drugs, immunosuppressive agents or cholesterol-
lowering drugs (Bode and Muller 2005; Gullo et al. 2006;
Newman and Cragg 2007). More than half of all known
antibiotics originate from the streptomycetes (Berdy
1995; Challis and Hopwood 2003), and many more clearly
remain to be discovered. A statistical analysis of antibiotic
discovery has predicted that streptomycetes may have the
capacity to produce as many as 105 secondary metabolites
(Watve et al. 2001). The finding that a single genus can carry
such a massive number of secondary metabolite biosyn-
thetic gene clusters is correlated with the location of many
of them in the arm regions of the chromosome, which are
extremely variable between species. In a few cases, such
clusters have been shown to be plasmid-borne. Thus, the
365-kb plasmid SCP1 of Streptomyces coelicolor carries
the biosynthetic gene cluster for methylenomycin A (Kirby
and Hopwood 1977; Bentley et al. 2004), and the
210-kb plasmid pSLA-2 of Streptomyces rochei carries four
secondary metabolite biosynthetic gene clusters: three poly-
ketide synthase (PKS) clusters (for lankacidin, lankamycin,
and a mithramycin-like compound) and a carotenoid biosyn-
thetic cluster (Mochizuki et al. 2003).
One of the most important industrial streptomycete
species is Streptomyces clavuligerus. Multiple natural prod-
ucts from this organism have been structurally and function-
ally characterized, and two of these are used in the clinic,
the b-lactam antibiotic cephamycin C (Alexander and
Jensen 1998), and the b-lactamase inhibitor clavulanic acid
(Saudagar et al. 2008). Clavulanic acid is widely used in com-
bination with the semisynthetic b-lactam amoxicillin to treat
various bacterial infections (Brogden et al. 1981). The bio-
synthetic genes for both compounds are encoded by a single
intensively studied gene supercluster (Liras et al. 2008). Sev-
eral clavam antibiotics closely related to these b-lactam ring-
containing compounds are also produced by S. clavuligerus
and are encoded by separate gene clusters (Evans et al. 1983;
Tahlan, Anders, and Jensen 2004; Tahlan, Park, and Jensen
2004; Tahlan, Park, Wong, et al. 2004; Tahlan et al. 2007;
Zelyas et al. 2008). At least three additional antibiotics have
been reported to be produced by S. clavuligerus, although no
biosynthetic genes for these have been described: the pyrro-
thine class antibiotic holomycin (Kenig and Reading 1979;
Oliva et al. 2001), a tacrolimus-like macrolide (Kim and Park
2008), and a compound related to the nucleoside antibiotic
tunicamycin (Kenig and Reading 1979).
Here, we describe the genome sequence of S. clavulige-
rus ATCC 27064 and show that this species has a unique
1.8-Mb linear megaplasmid, which is densely packed with
25 putative secondary metabolite gene clusters, in addition
to its 6.8-Mb chromosome, which also contains 23 such
clusters. Some of these clusters strongly resemble known
antibiotic gene clusters, others appear to be completely
novel, and a number show extravagant features that have
never been observed before. The megaplasmid found in
S. clavuligerus is by far the largest linear megaplasmid ever
sequenced, and its gene complement sheds light on the
rapid and dynamic evolution of secondary metabolite rep-
ertoires in bacteria, in addition to being a rich and compact
potential source of novel bioactive metabolites.
Materials and Methods
Genome Sequencing and Assembly
The genome of S. clavuligerus ATCC 27064 was sequenced
and assembled by random shotgun sequencing. Sanger se-
quencing of shotgun libraries with insert sizes of 3, 10, and
50 kb was accomplished using ABI 3700 sequencers as de-
scribed by Venter et al. (2001). Sequences were assembled
using Celera Assembler (Levy et al. 2007). Genome assem-
bly was facilitated and validated with an optical restriction
map (Latreille et al. 2007) acquired from OpGen (Madison
Wisconsin). Finally, as many gaps as possible were filled us-
ing sequences from a cosmid library created in-house at the
DSM Biotechnology Center. We estimate the final genome
assembly to be .99.7% complete.
Gene Prediction, Functional Annotation, and
Comparative Analysis
Straightforward gene prediction by Glimmer3 (Delcher et al.
2007) appeared to give a large number of false positives and
negatives. The high GC content of Streptomyces species
leads to the presence of many long open reading frames
(ORFs) which are not actual genes but only exist by coinci-
dence because of the low number of AT-rich stop codons.
These long reading frames often are not actual genes. There-
fore, we complemented Markov model-guided prediction by
Glimmer3 with mapping of BlastP searches of all putative
ORFs to the nonredundant (nr) protein database (using an
in-house Python script) and by analysis of the GC frame plots
in Artemis (Rutherford et al. 2000) to manually identify all
putative genes accurately.
Transfer RNA (tRNA) and tmRNA genes were identified
using ARAGORN, and ribosomal RNAs (rRNAs) were
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identified using the RNAmmer tool. For functional annota-
tion, all proteins were first processed with the AutoFACTau-
tomatic annotation pipeline (Koski et al. 2005) through
hierarchical information transfer from the best hits in the
Uniref90, NCBI nr, COG, KEGG, CDD, PFAM, and SMART
databases. A round of manual re-annotation followed to as-
certain the accuracy of the annotation.
Genome alignment of the DSM and Broad Institute draft
genomes was performed using the Mauve genome align-
ment program (Darling et al. 2004). Clusters of orthologous
groups were constructed using the OrthoMCL software (Li
et al. 2003), using cutoffs of e value ,1  1005 and iden-
tity .60%. Dotplots for genome comparison were created
with Gepard (Krumsiek et al. 2007). GC skew plots were
created using GenSkew (http://mips.gsf.de/services/analy-
sis/genskew/).
Phylogenetic analysis of plasmid-encoded transposase pro-
teins was performed as follows. The S. clavuligerus transpo-
sase sequences were blasted against the nr protein
database with BlastP. For each query sequence, the 25 best
blast hits were aligned using Muscle 3.6 (Edgar 2004), the
alignment was quality trimmed with Gblocks 0.91b (Talavera
and Castresana 2007), and an approximate maximum likeli-
hood phylogenetic tree was generated using FastTree 2.1.1
(http://www.microbesonline.org/fasttree/). Finally, all the hits
incorporated in the trees were blasted against a self-
assembled database of Streptomyces chromosomes to identify
transposases from Streptomyces chromosomal termini (dis-
tance,1 Mb to either end of the chromosome) using BlastX.
Query sequences present in a monophyletic taxon comprised
of at the most three proteins, in which at least one of the two
other proteins was a transposase from a Streptomyces chro-
mosomal terminus, were considered as positive hits.
Metabolic Model Construction
Published genome-scale metabolic models of S. coelicolor,
Escherichia coli, and Saccharomyces cerevisiae (Duarte
et al. 2004; Borodina et al. 2005; Feist et al. 2007) were used
together with a genome-scale model of Penicillium chryso-
genum (DSM, unpublished data) as a reference to construct
the metabolic model of S. clavuligerus. Gene-reaction asso-
ciations were putatively assigned to S. clavuligerus genes
based on sequence homology to genes included in the
reference genome-scale metabolic models. ‘‘Dead-end’’
metabolites (i.e., metabolites that are neither consumed
nor produced under any conditions) were identified, and
gaps were closed, if possible, by Blast searches on the
S. clavuligerus genome with enzymes from the KEGG data-
base that could connect dead-end metabolites. The gene-
reaction associations were further manually verified and cu-
rated using the Enzyme Commission (EC) numbers from the
functional annotation to correct for erroneous gene-reac-
tion associations. The metabolic model was checked for bio-
mass formation in silico under minimal growth medium
conditions (glycerol, ammonia, phosphate, and sulfate) us-
ing the COBRA toolbox (Becker et al. 2007). An SBML ver-
sion of the final model is available from the authors upon
request.
Results and Discussion
Architecture of the S. clavuligerus Genome
Pulse-field gel electrophoresis of restriction-digested frag-
ments in the nineties lead to an estimated size of 6.8 Mb
for the chromosome of S. clavuligerus (Chen et al. 1994). Ge-
nome sequencing and assembly confirmed this estimate but,
remarkably, a second large contig of 1.8 Mb was identified as
well.
The optical restriction map that we obtained indicated
that this second contig represents a separate replicon. This
was confirmed by almost perfectly symmetrical cumulative
GC skew plots of both contigs (supplementary fig. S1, Sup-
plementary Material online), characteristic for bacterial
chromosomes and plasmids (Grigoriev 1998). Origins of rep-
lication (Oris) were identified near the peak of the plots for
both replicons on the basis of homology.
The identification of the two large contigs was later in-
dependently confirmed by a prepublication draft sequence
from the Broad Institute (GenBank accession number
ABJH00000000), although our assembly of the 6.8-Mb re-
plicon differed from theirs by a large inversion at virtually
identical rRNA operons (supplementary fig. S2, Supplemen-
tary Material online). The optical restriction map that we ob-
tained and our GC skew analysis indicated that our assembly
is most probably correct.
The discovery of a second large replicon in S. clavuligerus is
not altogether surprising, as Kirby (1978) suspected the pres-
ence of a plasmid when he found that a genetic element
without linkage to the chromosome influenced holomycin
production. Intriguingly, pulse-field gel electrophoresis in
the closely related S. clavuligerus strain NRRL 3585—the type
strain which should be identical to strain ATCC 27064—has
shown the presence of three plasmids (pSCL1–3) ranging
in size between 11 and 430 kb (Netolitzky et al. 1995).
However, only a 7-kb replicon matching to the smallest of
these plasmids—the 11-kb plasmid pSCL1 (Wu and Roy
1993)—was identified in our assembly. No replicons of the
sizes reported for plasmids pSCL2 or pSCL3 were identified
in our assembly, and the nucleotide sequence of pSCL2 (Wu
et al. 2006) did not match to any part of our contigs in a
BlastN analysis. This implies that the evolution of streptomy-
cete genomes by plasmid acquisition, loss, or recombination
is extremely dynamic.
We identified 7,281 putative protein-encoding genes on
the two large replicons, as well as six rRNA operons, 72 tRNA
genes, and 14 pseudogenes (table 1). Strikingly, the sum of all
genomic features of the two replicons matches very well to
the typical make-up seen in other Streptomyces genomes.
Medema et al. GBE
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The 1.8-Mb Replicon Has the Hallmarks of a Giant
Linear Plasmid
We set out to characterize and compare the two replicons.
First of all, the central region of the 6.8-Mb replicon had very
large regions of conserved synteny to the chromosomes of
the four completed Streptomyces genomes, whereas the
smaller replicon had no regions with significant homology
to these chromosomes (supplementary fig. S3, Supplemen-
tary Material online). Moreover, the large replicon had an
origin of replication typical of Streptomyces chromosomes,
including dnaA and dnaN (SCLAV_2911–2912). The 6.8-Mb
replicon thus appears to represent a typical Streptomyces
chromosome. Interestingly, it is significantly smaller than
other published Streptomyces chromosomes, which range
in size between 8.5 and 9.0 Mb (Bentley et al. 2002; Ikeda
et al. 2003; Ohnishi et al. 2008) (table 1). Comparative anal-
ysis shows that the conserved core region of Streptomyces
chromosomes is present in S. clavuligerus, yet the typical
large chromosomal arms are not (supplementary fig. S3,
Supplementary Material online).
As stated in the previous section, the smaller replicon ap-
peared to have its own Ori, highly homologous to those of
the S. coelicolor plasmid SCP1 and the S. rochei plasmid
pSLA2-L, two Streptomyces plasmids that are known to har-
bor secondary metabolite gene clusters. The Ori lies at
around 945 kb, adjacent to close homologues of the plas-
mid-type DNA primase/replication proteins Orf1 and Orf2
(SCLAV_p0889 and SCLAV_p0888) from the S. coelicolor
SCP1 plasmid (Redenbach et al. 1999) and an additional
DNA primase/polymerase (SCLAV_p0890).
Both replicons have genes that encode ParAB chromosome
partitioning proteins near their predicted Ori (,10 kb). The
parAB genes of the 6.8-Mb replicon (SCLAV_2901–2902)
strongly resemble the S. griseus and S. avermitilis chromo-
somal parAB genes, whereas the parAB genes of the
1.8-Mb replicon (SCLAV_p0884–0885) are plasmid-type
and strongly resemble the parAB genes on the SCP1 plasmid
of S. coelicolor A3(2) (supplementary fig. S4, Supplementary
Material online).
The smaller replicon also has its own tap and tpg genes,
which encode proteins necessary for telomere replication of
Streptomyces chromosomes and plasmids (Bao and Cohen
2001, 2003). No tap or tpg genes were identified on the
main chromosome, as for the Rhodococcus sp. RHA1 ge-
nome (McLeod et al. 2006). The chromosome therefore
seems to depend on the tap/tpg genes of the smaller repli-
con. However, there could also be a different, unknown, sys-
tem for telomere replication; the recent identification of the
tac/tpc system (not present on the S. clavuligerus chromo-
some) of the S. coelicolor SCP1 plasmid shows that the tap/
tpg system is not universal for streptomycete chromosomes
and plasmids (Huang et al. 2007).
Genes for conjugative transfer were also detected on
both replicons. Again, although the chromosome carries
typical chromosomal-type traAB genes (SCLAV_4235–
4236), the smaller replicon has plasmid-type traAB genes
(SCLAV_p0254–0255) similar to those of the S. coelicolor
plasmid SCP2 (Brolle et al. 1993).
Based on these observations, we conclude that the 1.8-
Mb replicon has all the hallmarks of being a giant version of
a typical Streptomyces linear plasmid.
The Smaller Replicon Is a Megaplasmid Predicted
to be Dispensable for the Core Metabolism of
S. clavuligerus
Extrachromosomal genetic elements of bacteria can have
quite different functions compared to the chromosomes.
In some cases, they encode only accessory functions,
whereas in others they have evolved to encode essential cel-
lular functions as well. Although megaplasmids and chro-
mosomes are part of a continuous spectrum, Bentley and
Parkhill (2004) have proposed to distinguish chromosomes
from megaplasmids not by their replication genes but by
whether they are essential for growth of the organism
and whether they carry rRNA operons. We therefore set
out to predict whether the 1.8-Mb replicon is essential
for growth of S. clavuligerus.
Strikingly, all stable RNAs necessary for primary metabo-
lism (rRNA and tRNAs) are encoded on the main chromo-
some (table 1). A few putative tRNAs are encoded on the
1.8-Mb replicon, but these appear functionally redundant
compared with those on the chromosome according to their
Table 1
Genome Architecture of Streptomyces clavuligerus ATCC 27064
S. clavuligerus Streptomyces coelicolor S. avermitilis S. griseus
Chromosome pSCL4 Total Chromosome Chromosome Chromosome
Sequence length 6.760 Mb 1.796 Mb 8.556 Mb 8.668 Mb 8.546 Mb 9.026 Mb
GC% 72% 72% 72% 72% 72% 71%
rRNA operons 6 0 6 6 6 6
tRNAs 66 7 73 63 68 66
tmRNAs 1 0 1 1 1 1
Coding sequences 5,700 1,581 7,281 7,825 7,574 7,138
Secondary metabolite clusters 23 25 48 20 30 34
A Megaplasmid Dedicated to Secondary Metabolism GBE
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amino acid specificity and anticodon sequence. To investi-
gate whether the protein-coding genes of the replicon
are likely to be involved in essential cellular functions,
a Streptomyces core genome (Ussery et al. 2008) of 976
genes was defined, with each gene representing a cluster
of orthologous genes present in all four completed Strepto-
myces genomes. This core genome had only 14 significant
BlastP hits (e value , 1  1005 and identity .60%) to the
1.8-Mb replicon, distributed throughout its length, with
none appearing to be required for crucial cellular processes
(see supplementary table S1, Supplementary Material on-
line). Furthermore, all 21 out of the 24 Streptomyces-
specific signature genes (Ohnishi et al. 2008) that are
present in the S. clavuligerus genome are located on the
S. clavuligerus chromosome. Therefore, the 1.8-Mb replicon
does not seem to encode any of the essential genetic com-
plement of S. clavuligerus ATCC 27064. This is corroborated
by the fact that almost all the genes with the highest codon
adaptation indexes and third codon GC percentages
(GC3s)—which are likely to have housekeeping functions
(Wu et al. 2005)—lie on the chromosome (supplementary
fig. S5, Supplementary Material online).
In order to predict whether S. clavuligerus could grow nor-
mally using standard carbon and nitrogen sources without
the help of enzymes encoded on the 1.8-Mb replicon, we
constructed a metabolic model based on our functional an-
notation, comparisons with known metabolic models from
other organisms (Duarte et al. 2004; Borodina et al. 2005;
Feist et al. 2007), and subsequent gap filling (table 2). This
model successfully simulated growth of S. clavuligerus on
various carbon and nitrogen sources. In silico knock-outs
of all enzyme-coding genes specific to the 1.8-Mb replicon
resulted in no growth defects when growth was simulated
using glycerol as a carbon source. This suggests that no es-
sential genes of primary metabolism lie on the megaplasmid.
Nonetheless, a few enzymes for primary metabolism
were found to be encoded on the 1.8-Mb replicon. Among
them are malate synthase and isocitrate lyase, enzymes of
the glyoxylate pathway required for bacteria to grow on ac-
etate. However, there is a malate synthase isoenzyme gene
on the chromosome, which has been experimentally verified
before (Chan and Sim 1998), and copies of alternative ac-
tinomycete glyoxylate pathway genes (ccr/meaA and mcl1;
Akopiants et al. 2006) were also detected on the main chro-
mosome, possibly making the plasmid-encoded copies re-
dundant. Therefore, we predict that, even when growing
on alternative carbon sources, the 1.8-Mb replicon is dis-
pensable for primary metabolism. Experimental analysis
by either curing of the whole replicon or constructing mul-
tiple targeted knock-outs should confirm this.
As the 1.8-Mb replicon does not seem to encode any
functions essential to primary metabolism, the definition
of Bentley and Parkhill supports the labeling of the 1.8-
Mb replicon as a megaplasmid. As it is the fourth S. clavu-
ligerus plasmid to be described, we name it pSCL4. It is the
largest linear plasmid ever sequenced (Molbak et al. 2003).
If the above definition is strictly applied, pSCL4 is actually the
largest plasmid ever sequenced, as the only larger plasmid
(the circular plasmid pGMI1000MP from Ralstonia solana-
cearum Salanoubat et al. 2002) should then be classified
as a chromosome: it contains an important part of the met-
abolic core (an rRNA locus with two tRNA genes, a gene
coding for the alpha subunit of DNA polymerase III, a gene
for the protein elongation factor G, as well as several impor-
tant enzymes of primary metabolism, including amino acid
and cofactor biosynthesis), and thus is probably essential un-
der many growth conditions (Salanoubat et al. 2002).
TheMegaplasmid IsPackedwithSecondaryMetabolite
Gene Clusters
As the pSCL4 megaplasmid does not appear to harbor any
housekeeping genes, we were interested in predicting the
biological role of such a giant replicon. To our surprise,
pSCL4 is packed with gene clusters putatively encoding
the biosynthesis of secondary metabolites. No fewer than
25 such gene clusters, a number on the same order as ob-
served in the chromosomes of other Streptomyces ge-
nomes, are dispersed throughout the plasmid (fig. 1).
Together with the clusters identified on the chromosome,
the total number of putative secondary metabolite gene
clusters (SMC) identified in S. clavuligerus is 48, a number
unprecedented in any bacterium (fig. 2A and B). These in-
clude 10 putative nonribosomal peptide synthetase (NRPS)
gene clusters, eight putative PKS gene clusters, and six gene
clusters putatively encoding NRPSs and PKSs or NRPS-PKS
hybrids, as well as 12 clusters putatively encoding one or
more terpene synthases or cyclases. An overview of all clus-
ters encoding putative NRPSs and PKSs is shown in figure 2,
and further details are given in supplementary table S2 (Sup-
plementary Material online).
As expected, the three known antibiotic gene clusters
of S. clavuligerus were identified in our genome assembly.
Although the supercluster encoding the clavulanic acid
and cephamycin C biosynthetic pathways (SMC10-11)
and one of the clavam clusters (Tahlan et al. 2007)
(SMC9) lie on the main chromosome, the alanylclavam
Table 2
Genome-Scale Metabolic Model of Streptomyces clavuligerus
Number of reactions 1,492
Number of metabolites (internal/external) 971/202
Dimensions of S (metabolites by reactions) 1,492  1,173
Number of internal fluxes 1,290
Number of exchange fluxes 202
Number of chromosomal genes included 785
Number of plasmid genes included 79
Total number of genes included 864
Number of essential genes 100
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cluster (SMCp13) (Zelyas et al. 2008) is located on the meg-
aplasmid. The latter cluster has been called a ‘‘paralogous
cluster’’ of the clavulanic acid gene cluster (Tahlan, Park,
Wong, et al. 2004) and was thought to have arisen through
a recent gene duplication. Interestingly, a previously un-
known third cluster of genes (SMCp25) containing a more
distant homolog of the clavaminate synthase gene was also
identified on pSCL4. This cluster might encode the produc-
tion of yet another b-lactam antibiotic.
We could not predict with certainty which gene clusters
are responsible for the production of holomycin and the tu-
nicamycin-related antibiotic, given the paucity of knowledge
on their biosynthesis. For the tacrolimus-like macrolide, we
identified a potential gene cluster: the only macrolide PKS
cluster detected, consisting of 11 modules. It is positioned
near the end of one of the chromosomal arms (SMC1).
Interestingly, we also identified gene clusters potentially
encoding the biosynthesis of known antibiotics on the meg-
aplasmid. Clusters closely homologous to the staurosporine
biosynthetic gene cluster of Streptomyces sp. TP-A0274
(Onaka et al. 2002) (SMCp14) and the moenomycin biosyn-
thetic gene cluster from Streptomyces ghanaensis (Ostash
et al. 2007, 2009) (SMCp18) were detected, as well as
a close homolog of the IndC indigoidine blue pigment syn-
thetase from Streptomyces lavendulae (Takahashi et al.
2007) (SMCp24). The fact that pSCL4 carries multiple bio-
synthetic gene clusters closely resembling those in relatively
distantly related Streptomyces species, whereas the same
clusters are absent in more closely related species (supple-
mentary fig. S6, Supplementary Material online), supports
the hypothesis that many secondary metabolism biosyn-
thetic gene clusters in bacteria are acquired by horizontal
gene transfer.
Putative gene clusters that might encode unknown prod-
ucts were also identified on both the megaplasmid and the
chromosome. These include two enediyne-type PKS clusters
on the megaplasmid (SMCp16 and SMCp21), which have
the typical unbLVU genes encoding the biosynthetic ma-
chinery for the core enediyne structure. The clusters are
quite similar to the biosynthetic gene clusters of C-1027
(Liu et al. 2002) and calicheamycin (Ahlert et al. 2002). Both
S. clavuligerus clusters fall into the phylogenetic subgroup of
nine-membered enediyne polyketides that was recently
identified (Udwary et al. 2007) (supplementary fig. S7, Sup-
plementary Material online), although we should note that
recombination might have occurred between the two clus-
ters (we observed some extremely similar regions in the mul-
tiple sequence alignments of these PKSs) which might
distort the phylogenetic analysis.
The second enediyne-type PKS cluster lies very close to an
NRPS gene cluster (SMCp20) with a very unusual feature that
has not been observed before: the module containing the thi-
oesterase is fused C-terminally to a major facilitator-type
transporter. This may be used to export the end product from
the cell immediately after assembly. Such a mechanism could
have the advantage that the transport efficiency of the sub-
stance is much higher, and the cell can synthesize highly toxic
compounds without these poisoning the producing cell.
Yet another remarkable cluster (SMC14) on the chro-
mosome has one of its putative NRPS modules fused to
a b-lactamase domain (PFAM number PF00144). No signif-
icant resemblance of this domain to any experimentally
studied protein was detected, so we can only speculate
about its function: it might, for example, act as a transpep-
tidase or bind to, but not hydrolyze, a b-lactam compound
that is then attached to the peptide synthesized by
FIG. 1.—Overview of the putative secondary metabolite gene clusters in the Streptomyces clavuligerus genome. Chromosomal maps of the S.
clavuligerus genome, showing both the chromosome and the megaplasmid pSCL4. SMC: secondary metabolite gene clusters, shown in different colors
according to their type. CDS: coding sequences. GC%: GC percentage around the midline average of 72%. GC skew: GC skew, positive (brown) or
negative (purple).
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the NRPS. Generally, these domains are of high importance
in b-lactam producing organisms, as they can catalyze the
opening and hydrolysis of the b-lactam ring of b-lactam
antibiotics and can thus provide resistance to the strain’s
own antibiotics. Twenty-two proteins carrying a predicted
b-lactamase domain were detected on the chromosome or
plasmid (supplementary table S3, Supplementary Material
online).
Cross-regulationTakesPlacebetweentheMegaplasmid
and the Chromosome
Expression of secondary metabolite genes can be regulated
in a variety of ways. One important regulatory mechanism
involves small signaling molecules called c-butyrolactones
(Takano 2006). In S. clavuligerus, a gene encoding a c-bu-
tyrolactone receptor protein (ScaR/Brp) was recently identi-
fied and shown to regulate clavulanic acid and cephamycin
C production (Kim et al. 2004; Santamarta et al. 2005). We
identified this gene as the megaplasmid-encoded
SCLAV_p0894, which appeared to be the only c-butyrolac-
tone receptor protein-encoding gene in the entire genome.
However, four ScbA/AfsA-like putative butyrolactone bio-
synthetic proteins were detected: three on the chromosome
(SCLAV_0463, SCLAV_0471, SCLAV_2310) and one on the
megaplasmid (SCLAV_p0812). Based on phylogenetic anal-
ysis (supplementary fig. S8, Supplementary Material online),
SCLAV_2310 is the most likely candidate for being involved
in butyrolactone biosynthesis. The fact that the only c-bu-
tyrolactone receptor protein is encoded on the megaplas-
mid is remarkable, as all other characterized
c-butyrolactone receptors are chromosomally encoded.
Moreover, it means that Brp transregulates several factors
on the chromosome (at least the cephamycin C and clavu-
lanic acid gene clusters). Because in a phylogenetic analysis,
Brp was shown to cluster together with all known chromo-
somally encoded c-butyrolactone receptors (Nishida et al.
2007), one is tempted to speculate that this gene was orig-
inally derived from the main chromosome and became
plasmid-borne through recombination or transposition.
Interestingly, two of the AfsA domain-containing butyrolac-
tone biosynthetic proteins (SCLAV_0463 and SCLAV_0471)
lie in a PKS gene cluster (SMC5), which consequently might
be regulated by butyrolactone signaling.
Other regulatory genes were also identified. Fifty sigma
factor genes were found, of which 43 lie on the chromo-
some and seven on pSCL4. Fifty-one paired two-component
regulatory systems were identified, of which 44 are encoded
on the chromosome and seven on the megaplasmid. Also,
21 orphan response regulator genes and eight orphan his-
tidine kinase genes were identified. The two-component
systems include at least five (chromosomally encoded) very
close homologues of systems that have been observed to be
involved in the regulation of antibiotic biosynthesis: AfsQ12
(SCLAV_3812–3813) (Ishizuka et al. 1992), CutRS (SCLAV_
4778–4779) (Chang et al. 1996), RapA12 (SCLAV_4312–
4313) (Lu et al. 2007), AbrB12 (SCLAV_1381–1382) and
AbiA123 (SCLAV_3595–3597). Additionally, 26 serine/thre-
onine kinase genes were detected, of which only two are on
the megaplasmid. Finally, 20 Streptomyces antibiotic regu-
latory protein (SARP) genes were detected, of which eight
FIG. 3.—Three scenarios for the evolution of megaplasmid pSCL4. (A) A double crossover between the chromosomal core and the core of
a smaller plasmid. (B) Two consecutive recombination events, the first yielding an asymmetrical plasmid and the second a symmetrical one. (C)
Integration of a relatively small plasmid into a chromosomal arm and subsequent breaking off of the arm to yield an independent replicon.
FIG. 2.—Secondary metabolite biosynthetic gene clusters: a detailed picture. Putative secondary metabolite gene clusters (SMCs) encoding NRPSs
and PKSs on (A) the chromosome and (B) the megaplasmid pSCL4 of Streptomyces clavuligerus ATCC 27064. Different core and accessory genes are
depicted in different colors as indicated. Cluster borders are approximate and were estimated on the basis of functional annotations and putative
operon structures. Details on the putative secondary metabolite gene clusters not shown in this figure (encoding b-lactams, terpene synthases,
lantibiotics, etc.) can be found in supplementary table 2 (Supplementary Material online).
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are on the megaplasmid. Seven SARPs are encoded in or
very near secondary metabolism gene clusters.
The vast array of potential regulatory mechanisms sug-
gests that the production of secondary metabolites in S.
clavuligerus—as in other streptomycetes—is under complex
regulation, being highly tuned to the specific needs of the
organism. It is striking that for all classes of regulators, the
plasmid seems to encode considerably fewer compared with
the chromosome, reinforcing the view that it is a highly spe-
cialized genetic element.
Scenarios for the Evolution of pSCL4
The small size of the S. clavuligerus chromosome and the
functional similarity between pSCL4 and Streptomyces chro-
mosomal arms prompted the question how a megaplasmid-
like pSCL4could have originated. Interestingly, a megaplasmid
or chromosome of very similar size (1.8 Mb) has been ob-
served in S. coelicolor A3(2), after a single crossover between
the 365-kb SCP1 plasmid and the chromosome (Yamasaki
and Kinashi 2004). However, such a simple single crossover
cannot have produced a plasmid configuration as seen in
pSCL4, as it would have lead to an asymmetrical replicon with
the Ori located distantly from the centre (fig. 3B, upper part).
The central position of the pSCL4 Ori suggests that multiple
recombination events have taken place either simultaneously
or consecutively. Furthermore, the small size of the main chro-
mosome compared to those of other Streptomyces species
suggests that the plasmid may well have been endowed with
genetic regions from the chromosome arms in the recent
past. Other observations that should also be taken into
account are the clustering of replication genes (parAB, tap/
tpg, plasmid primase/replicase genes) and other important
genes such as the butyrolactone receptor gene brp close
to the plasmid Ori, and the existence of a region close to
the plasmid Ori (SCLAV_p0926–0939) similar to chromo-
somal regions of many other actinomycetes but not found
on the S. clavuligerus chromosome. These considerations sug-
gest three possible scenarios for the origin of pSCL4 (fig. 3).
According to the first scenario, a relatively small plasmid
underwent double crossing over with the chromosomal
core, to yield a core chromosome with small plasmid arms
and a plasmid core with large chromosomal arms. The sec-
ond scenario is a variant of the first but postulates two asyn-
chronous recombination events: first, a smaller plasmid
recombined with one chromosomal arm, yielding an asym-
metrical plasmid and then this situation was stabilized by
another recombination with the other chromosomal arm.
In the third scenario, a small integrative plasmid would have
integrated into one of the chromosomal arms, after which it
would have broken off (e.g., during conjugative transfer)
and become a separate replicon.
The first two scenarios both seem parsimonious, as they
can explain the symmetrical GC skew plot of pSCL4 without
the need for extensive subsequent evolutionary fine-tuning.
Moreover, these scenarios are also favored over the third be-
cause the main chromosome is quite symmetrical despite its
small size and has long arms on neither side. A final argu-
ment supporting the first and second scenarios is provided
by the distribution of transposons throughout the S. clavu-
ligerus genome. Normally, many transposons are present at
the far termini of the main chromosomes of streptomycetes
(Chen et al. 2002), yet they are absent from the termini of
the S. clavuligerus chromosome. Instead, many transposons
are present near the termini of pSCL4 (44 in total, judged by
the number of transposases found; fig. 4). Intriguingly, phy-
logenetic analysis showed that most of these (25 of the 44)
are close homologues of transposases encoded in Strepto-
myces chromosomal termini (,1-Mb distance to the ends).
This suggests that the plasmid may indeed contain the for-
mer chromosomal termini of S. clavuligerus. Sequencing of
FIG. 4.—Transposases in Streptomyces genomes. Transposases
identified in the Streptomyces clavuligerus genome compared with
the transposases identified in the genomes of Streptomyces coelicolor,
S. avermitilis, and S. griseus. In contrast to the three other genomes, the
chromosome of S. clavuligerus does not encode a large number of
transposases at its ends. However, pSCL4 does encode many trans-
posases. The fact that this feature—typical of chromosomal ends—is
not present in the chromosome, yet present in the plasmid supports the
hypothesis that the plasmid originated by acquiring the terminal regions
of the chromosome.
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the telomeres at the very ends of chromosome and mega-
plasmid might help to confirm this.
Heavy Traffic between Plasmids and Chromosomal
Arms in Actinomycete Bacteria
Our findings underline the dynamic evolution of actinomy-
cete genomes. They seem to acquire or lose plasmids regu-
larly, and the gene content of their chromosomal arms
fluctuates dramatically (Choulet et al. 2006). This is clearly
visible in the phylogeny of the Tpg telomere proteins
(fig. 5), which shows almost complete intermixing of chromo-
some- and plasmid-encoded genes, signifying extensive
transfer of tpg genes via recombination or integration. Our
identification of a very large plasmid densely packed with ge-
netic material that is typically encoded on chromosomal arms
suggests that linear plasmids play a major role in this genomic
flux. Because of their ability to reach large sizes and the pos-
sibility of plasmid–chromosome recombination or plasmid in-
tegration (Kinashi et al. 1992) such as described above,
plasmids seem to be more important than previously thought
in determining the large variability of actinomycete genomes.
This hypothesis fits neatly with the observation that many ac-
tinomycete species-specific secondary metabolite clusters are
located within genomic islands (Penn et al. 2009), which are
often mobilized on plasmids (Dobrindt et al. 2004). The fact
that the S. clavuligerus ATCC 27064 strain appears to have
a very different genome composition in terms of plasmids
than the NRRL 3585 strain (Netolitzky et al. 1995)—which
originates from the same source (Higgens and Kastner
1971)—epitomizes the highly dynamic nature of actinomy-
cete plasmids. Earlier observations of rapid recombination
events between chromosomes and plasmids (Gravius et al.
1994; McLeod et al. 2006) in actinomycetes with linear chro-
mosomes had already suggested such a conclusion.
Conclusions
The sequencing of the genome of S. clavuligerus reveals the
potential for producing a vast array of interesting novel sec-
ondary metabolites, some of them encoded by unusual gene
configurations that have never been observed before. The
fact that a major part of the secondary metabolite biosynthe-
sis gene clusters is localized on a specialized giant linear plas-
mid (pSCL4), which we predict not to contain any genes
essential for primary metabolism, indicates that plasmids
could more often encode secondary metabolites than previ-
ously thought (Kinashi 2008). The small size of the S. clavu-
ligerus chromosome and the absence of hallmarks typical for
Streptomyces chromosomal termini, together with the re-
markable presence of such terminal hallmarks on the plasmid,
suggest that the megaplasmid may have originated by a dou-
ble recombination of a smaller plasmid with the chromosome.
There is evidence that cross-regulation of chromosomal genes
by at least one plasmid-encoded regulator still occurs. Intrigu-
ingly, the deduced flow of genetic material between different
replicons may not be an exception: the phylogeny of telomere
replication proteins from plasmids as well as chromosomes
suggests that fluxes of genetic material regularly take place
between streptomycete chromosomes and plasmids. Indeed,
the mobilization of secondary metabolite gene clusters onto
large linear plasmids such as pSCL4, which could be vectors
for horizontal gene transfer (Ravel et al. 1998, 2000), indi-
cates that constant and extensive ‘‘open source’’ evolution
(Frost et al. 2005) of secondary metabolite-encoding DNA re-
gions in actinomycetes could be responsible for the large dif-
ferences in secondary metabolite repertoires between
different species. Approaches that ‘‘awaken’’ uncharacterized
gene clusters will undoubtedly be pivotal to uncover the func-
tionalities of the secondary metabolites they encode (Scher-
lach and Hertweck 2009). Furthermore, if the plasmid could
be cured from the strain (Hsu and Chen 2010), the small
FIG. 5.—Phylogeny of Tpg proteins shows the dynamic evolution of linear plasmids and chromosomes in Streptomyces. Phylogenetic analysis of
Tpg proteins shows that there is no correlation between the phylogenetic clustering and presence of a tpg gene on either the plasmid (in dark gray) or
the chromosome (in light gray). This suggests that tap and tpg genes are often transferred from chromosomes to plasmids and vice versa, for example,
through recombination. Phylogenies were calculated using the neighbor-joining (NJ) method in MEGA 4 (Tamura et al. 2007). The percentage of
replicate trees in which the associated taxa clustered together in the bootstrap test (100 replicates) is shown next to the branches.
A Megaplasmid Dedicated to Secondary Metabolism GBE
Genome Biol. Evol. 2:212–224. doi:10.1093/gbe/evq013 Advance Access publication March 29, 2010 221
chromosome of S. clavuligerus may be a very interesting ve-
hicle for synthetic biology (Keasling 2008), serving asa starting
point for the construction of a ‘‘minimal streptomycete.’’
Supplementary Material
Supplementary figures S1–S8 and tables 1 and 2 are avail-
able at Genome Biology and Evolution online (http://
www.oxfordjournals.org/our_journals/gbe/).
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